Metabolism and Excretion of Nirmatrelvir in Humans Using Quantitative Fluorine Nuclear Magnetic Resonance Spectroscopy: A Novel Approach for Accelerating Drug Development.

Saved in:
Bibliographic Details
Title: Metabolism and Excretion of Nirmatrelvir in Humans Using Quantitative Fluorine Nuclear Magnetic Resonance Spectroscopy: A Novel Approach for Accelerating Drug Development.
Authors: Singh RSP; Pfizer Worldwide Research, Development & Medical, Cambridge, Massachusetts, USA., Walker GS; Pfizer Worldwide Research, Development & Medical, Groton, Connecticut, USA., Kadar EP; Pfizer Worldwide Research, Development & Medical, Groton, Connecticut, USA., Cox LM; Pfizer Worldwide Research, Development & Medical, Groton, Connecticut, USA., Eng H; Pfizer Worldwide Research, Development & Medical, Groton, Connecticut, USA., Sharma R; Pfizer Worldwide Research, Development & Medical, Groton, Connecticut, USA., Bergman AJ; Pfizer Worldwide Research, Development & Medical, Cambridge, Massachusetts, USA., Van Eyck L; Pfizer Clinical Research Unit, Brussels, Belgium., Hackman F; Pfizer Worldwide Research, Development and Medical, Cambridge, UK., Toussi SS; Pfizer Clinical Development, Pearl River, New York, USA., Kalgutkar AS; Pfizer Worldwide Research, Development & Medical, Cambridge, Massachusetts, USA., Obach RS; Pfizer Worldwide Research, Development & Medical, Groton, Connecticut, USA.
Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 Dec; Vol. 112 (6), pp. 1201-1206. Date of Electronic Publication: 2022 Jun 29.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first